| 0023-5301 | These highlights do not include all the information needed to use RESTASIS MULTIDOSE safely and effectively. See full prescribing information for RESTASIS MULTIDOSE . RESTASIS MULTIDOSE ® ( cyclosporine ophthalmic emulsion ) 0.05% , f or topical ophthalmic use Initial U.S. Approval: 1983 | Allergan, Inc. |
| 0023-5301-05 | These highlights do not include all the information needed to use RESTASIS MULTIDOSE safely and effectively. See full prescribing information for RESTASIS MULTIDOSE . RESTASIS MULTIDOSE ® ( cyclosporine ophthalmic emulsion ) 0.05% , f or topical ophthalmic use Initial U.S. Approval: 1983 | Allergan, Inc. |
| 0023-5301-08 | These highlights do not include all the information needed to use RESTASIS MULTIDOSE safely and effectively. See full prescribing information for RESTASIS MULTIDOSE . RESTASIS MULTIDOSE ® ( cyclosporine ophthalmic emulsion ) 0.05% , f or topical ophthalmic use Initial U.S. Approval: 1983 | Allergan, Inc. |
| 0023-9163 | These highlights do not include all the information needed to use RESTASIS ® 0.05% safely and effectively. See full prescribing information for RESTASIS ® . RESTASIS ® ( cyclosporine ophthalmic emulsion ) 0.05% For topical ophthalmic use Initial U.S. Approval: 1983 | A-S Medication Solutions |
| 0023-9163 | These highlights do not include all the information needed to use RESTASIS 0.05% safely and effectively. See full prescribing information for RESTASIS . RESTASIS ® ( cyclosporine ophthalmic emulsion ) 0.05% For topical ophthalmic use Initial U.S. Approval: 1983 | Allergan, Inc. |
| 0023-9163 | RESTASIS ® (cyclosporine ophthalmic emulsion) 0.05% | Physicians Total Care, Inc. |
| 0023-9163 | These highlights do not include all the information needed to use RESTASIS ® 0.05% safely and effectively. See full prescribing information for RESTASIS ® . RESTASIS ® ( cyclosporine ophthalmic emulsion ) 0.05% For topical ophthalmic use Initial U.S. Approval: 1983 | A-S Medication Solutions |
| 0023-9163-12 | These highlights do not include all the information needed to use RESTASIS 0.05% safely and effectively. See full prescribing information for RESTASIS . RESTASIS ® ( cyclosporine ophthalmic emulsion ) 0.05% For topical ophthalmic use Initial U.S. Approval: 1983 | Allergan, Inc. |
| 0023-9163-30 | These highlights do not include all the information needed to use RESTASIS 0.05% safely and effectively. See full prescribing information for RESTASIS . RESTASIS ® ( cyclosporine ophthalmic emulsion ) 0.05% For topical ophthalmic use Initial U.S. Approval: 1983 | Allergan, Inc. |
| 0023-9163-60 | These highlights do not include all the information needed to use RESTASIS 0.05% safely and effectively. See full prescribing information for RESTASIS . RESTASIS ® ( cyclosporine ophthalmic emulsion ) 0.05% For topical ophthalmic use Initial U.S. Approval: 1983 | Allergan, Inc. |
| 0061-1088 | Optimmune ® (0.2% Cyclosporine, USP) Ophthalmic Ointment | Merck Sharp & Dohme Corp. |
| 0061-1088-01 | Optimmune ® (0.2% Cyclosporine, USP) Ophthalmic Ointment | Merck Sharp & Dohme Corp. |
| 0074-0541 | GENGRAF ® Capsules (cyclosporine capsules, USP [MODIFIED]) | AbbVie Inc. |
| 0074-0541-30 | GENGRAF ® Capsules (cyclosporine capsules, USP [MODIFIED]) | AbbVie Inc. |
| 0074-3108 | GENGRAF ® Capsules (cyclosporine capsules, USP [MODIFIED]) | AbbVie Inc. |
| 0074-3108-32 | GENGRAF ® Capsules (cyclosporine capsules, USP [MODIFIED]) | AbbVie Inc. |
| 0074-3109 | GENGRAF ® Capsules (cyclosporine capsules, USP [MODIFIED]) | AbbVie Inc. |
| 0074-3109-32 | GENGRAF ® Capsules (cyclosporine capsules, USP [MODIFIED]) | AbbVie Inc. |
| 0074-6463 | GENGRAF ® Capsules (cyclosporine capsules, USP [MODIFIED]) | AbbVie Inc. |
| 0074-6463-32 | GENGRAF ® Capsules (cyclosporine capsules, USP [MODIFIED]) | AbbVie Inc. |
| 0074-6479 | GENGRAF ® Capsules (cyclosporine capsules, USP [MODIFIED]) | AbbVie Inc. |
| 0074-6479-32 | GENGRAF ® Capsules (cyclosporine capsules, USP [MODIFIED]) | AbbVie Inc. |
| 0078-0109 | Sandimmune ® Soft Gelatin Capsules (cyclosporine capsules, USP) Sandimmune ® Oral Solution (cyclosporine oral solution, USP) Sandimmune ® Injection (cyclosporine injection, USP) FOR INFUSION ONLY Rx only Prescribing Information | Novartis Pharmaceuticals Corporation |
| 0078-0109 | Sandimmune ® (cyclosporine capsules), for oral use Sandimmune ® (cyclosporine injection), for intravenous use Prescribing Information | Novartis Pharmaceuticals Corporation |
| 0078-0109-01 | Sandimmune ® Soft Gelatin Capsules (cyclosporine capsules, USP) Sandimmune ® Oral Solution (cyclosporine oral solution, USP) Sandimmune ® Injection (cyclosporine injection, USP) FOR INFUSION ONLY Rx only Prescribing Information | Novartis Pharmaceuticals Corporation |
| 0078-0109-01 | Sandimmune ® (cyclosporine capsules), for oral use Sandimmune ® (cyclosporine injection), for intravenous use Prescribing Information | Novartis Pharmaceuticals Corporation |
| 0078-0109-61 | Sandimmune ® Soft Gelatin Capsules (cyclosporine capsules, USP) Sandimmune ® Oral Solution (cyclosporine oral solution, USP) Sandimmune ® Injection (cyclosporine injection, USP) FOR INFUSION ONLY Rx only Prescribing Information | Novartis Pharmaceuticals Corporation |
| 0078-0109-61 | Sandimmune ® (cyclosporine capsules), for oral use Sandimmune ® (cyclosporine injection), for intravenous use Prescribing Information | Novartis Pharmaceuticals Corporation |
| 0078-0110 | Sandimmune ® Soft Gelatin Capsules (cyclosporine capsules, USP) Sandimmune ® Oral Solution (cyclosporine oral solution, USP) Sandimmune ® Injection (cyclosporine injection, USP) FOR INFUSION ONLY Rx only Prescribing Information | Novartis Pharmaceuticals Corporation |
| 0078-0110 | Sandimmune ® (cyclosporine capsules), for oral use Sandimmune ® (cyclosporine injection), for intravenous use Prescribing Information | Novartis Pharmaceuticals Corporation |
| 0078-0110-22 | Sandimmune ® Soft Gelatin Capsules (cyclosporine capsules, USP) Sandimmune ® Oral Solution (cyclosporine oral solution, USP) Sandimmune ® Injection (cyclosporine injection, USP) FOR INFUSION ONLY Rx only Prescribing Information | Novartis Pharmaceuticals Corporation |
| 0078-0110-22 | Sandimmune ® (cyclosporine capsules), for oral use Sandimmune ® (cyclosporine injection), for intravenous use Prescribing Information | Novartis Pharmaceuticals Corporation |
| 0078-0240 | Sandimmune ® Soft Gelatin Capsules (cyclosporine capsules, USP) Sandimmune ® Oral Solution (cyclosporine oral solution, USP) Sandimmune ® Injection (cyclosporine injection, USP) FOR INFUSION ONLY Rx only Prescribing Information | Novartis Pharmaceuticals Corporation |
| 0078-0240 | Sandimmune ® (cyclosporine capsules), for oral use Sandimmune ® (cyclosporine injection), for intravenous use Prescribing Information | Novartis Pharmaceuticals Corporation |
| 0078-0240-15 | Sandimmune ® (cyclosporine capsules), for oral use Sandimmune ® (cyclosporine injection), for intravenous use Prescribing Information | Novartis Pharmaceuticals Corporation |
| 0078-0240-15 | Sandimmune ® Soft Gelatin Capsules (cyclosporine capsules, USP) Sandimmune ® Oral Solution (cyclosporine oral solution, USP) Sandimmune ® Injection (cyclosporine injection, USP) FOR INFUSION ONLY Rx only Prescribing Information | Novartis Pharmaceuticals Corporation |
| 0078-0240-61 | Sandimmune ® (cyclosporine capsules), for oral use Sandimmune ® (cyclosporine injection), for intravenous use Prescribing Information | Novartis Pharmaceuticals Corporation |
| 0078-0240-61 | Sandimmune ® Soft Gelatin Capsules (cyclosporine capsules, USP) Sandimmune ® Oral Solution (cyclosporine oral solution, USP) Sandimmune ® Injection (cyclosporine injection, USP) FOR INFUSION ONLY Rx only Prescribing Information | Novartis Pharmaceuticals Corporation |
| 0078-0241 | Sandimmune ® Soft Gelatin Capsules (cyclosporine capsules, USP) Sandimmune ® Oral Solution (cyclosporine oral solution, USP) Sandimmune ® Injection (cyclosporine injection, USP) FOR INFUSION ONLY Rx only Prescribing Information | Novartis Pharmaceuticals Corporation |
| 0078-0241 | Sandimmune ® (cyclosporine capsules), for oral use Sandimmune ® (cyclosporine injection), for intravenous use Prescribing Information | Novartis Pharmaceuticals Corporation |
| 0078-0241-15 | Sandimmune ® Soft Gelatin Capsules (cyclosporine capsules, USP) Sandimmune ® Oral Solution (cyclosporine oral solution, USP) Sandimmune ® Injection (cyclosporine injection, USP) FOR INFUSION ONLY Rx only Prescribing Information | Novartis Pharmaceuticals Corporation |
| 0078-0241-15 | Sandimmune ® (cyclosporine capsules), for oral use Sandimmune ® (cyclosporine injection), for intravenous use Prescribing Information | Novartis Pharmaceuticals Corporation |
| 0078-0241-61 | Sandimmune ® Soft Gelatin Capsules (cyclosporine capsules, USP) Sandimmune ® Oral Solution (cyclosporine oral solution, USP) Sandimmune ® Injection (cyclosporine injection, USP) FOR INFUSION ONLY Rx only Prescribing Information | Novartis Pharmaceuticals Corporation |
| 0078-0241-61 | Sandimmune ® (cyclosporine capsules), for oral use Sandimmune ® (cyclosporine injection), for intravenous use Prescribing Information | Novartis Pharmaceuticals Corporation |
| 0078-0246 | NEORAL ® Soft Gelatin Capsules (cyclosporine capsules, USP) MODIFIED NEORAL ® Oral Solution (cyclosporine oral solution, USP) MODIFIED Rx only Prescribing Information | Novartis Pharmaceuticals Corporation |
| 0078-0246-15 | NEORAL ® Soft Gelatin Capsules (cyclosporine capsules, USP) MODIFIED NEORAL ® Oral Solution (cyclosporine oral solution, USP) MODIFIED Rx only Prescribing Information | Novartis Pharmaceuticals Corporation |
| 0078-0246-61 | NEORAL ® Soft Gelatin Capsules (cyclosporine capsules, USP) MODIFIED NEORAL ® Oral Solution (cyclosporine oral solution, USP) MODIFIED Rx only Prescribing Information | Novartis Pharmaceuticals Corporation |
| 0078-0248 | NEORAL ® Soft Gelatin Capsules (cyclosporine capsules, USP) MODIFIED NEORAL ® Oral Solution (cyclosporine oral solution, USP) MODIFIED Rx only Prescribing Information | Novartis Pharmaceuticals Corporation |
| 0078-0248-15 | NEORAL ® Soft Gelatin Capsules (cyclosporine capsules, USP) MODIFIED NEORAL ® Oral Solution (cyclosporine oral solution, USP) MODIFIED Rx only Prescribing Information | Novartis Pharmaceuticals Corporation |
| 0078-0248-61 | NEORAL ® Soft Gelatin Capsules (cyclosporine capsules, USP) MODIFIED NEORAL ® Oral Solution (cyclosporine oral solution, USP) MODIFIED Rx only Prescribing Information | Novartis Pharmaceuticals Corporation |
| 0078-0274 | NEORAL ® Soft Gelatin Capsules (cyclosporine capsules, USP) MODIFIED NEORAL ® Oral Solution (cyclosporine oral solution, USP) MODIFIED Rx only Prescribing Information | Novartis Pharmaceuticals Corporation |
| 0078-0274-22 | NEORAL ® Soft Gelatin Capsules (cyclosporine capsules, USP) MODIFIED NEORAL ® Oral Solution (cyclosporine oral solution, USP) MODIFIED Rx only Prescribing Information | Novartis Pharmaceuticals Corporation |
| 0093-9018 | cycloSPORINE Capsules, USP MODIFIED (Soft Gelatin Capsules) | Teva Pharmaceuticals USA, Inc. |
| 0093-9018-19 | cycloSPORINE Capsules, USP MODIFIED (Soft Gelatin Capsules) | Teva Pharmaceuticals USA, Inc. |
| 0093-9018-65 | cycloSPORINE Capsules, USP MODIFIED (Soft Gelatin Capsules) | Teva Pharmaceuticals USA, Inc. |
| 0093-9019 | cycloSPORINE Capsules, USP MODIFIED (Soft Gelatin Capsules) | Teva Pharmaceuticals USA, Inc. |
| 0093-9019-19 | cycloSPORINE Capsules, USP MODIFIED (Soft Gelatin Capsules) | Teva Pharmaceuticals USA, Inc. |
| 0093-9019-65 | cycloSPORINE Capsules, USP MODIFIED (Soft Gelatin Capsules) | Teva Pharmaceuticals USA, Inc. |
| 0093-9020 | cycloSPORINE Capsules, USP MODIFIED (Soft Gelatin Capsules) | Teva Pharmaceuticals USA, Inc. |
| 0093-9020-19 | cycloSPORINE Capsules, USP MODIFIED (Soft Gelatin Capsules) | Teva Pharmaceuticals USA, Inc. |
| 0093-9020-65 | cycloSPORINE Capsules, USP MODIFIED (Soft Gelatin Capsules) | Teva Pharmaceuticals USA, Inc. |
| 0172-7312 | CYCLOSPORINE CAPSULES USP MODIFIED (Soft Gelatin Capsules) Rx only | Physicians Total Care, Inc. |
| 0172-7313 | cycloSPORINE Oral Solution, USP MODIFIED | Teva Pharmaceuticals USA, Inc. |
| 0172-7313-20 | cycloSPORINE Oral Solution, USP MODIFIED | Teva Pharmaceuticals USA, Inc. |
| 0378-8760 | These highlights do not include all the information needed to use CYCLOSPORINE OPHTHALMIC EMULSION 0.05% safely and effectively. See full prescribing information for CYCLOSPORINE OPHTHALMIC EMULSION . CYCLOSPORINE ophthalmic emulsion 0.05% For topical ophthalmic use Initial U.S. Approval: 1983 | Mylan Pharmaceuticals Inc. |
| 0378-8760-58 | These highlights do not include all the information needed to use CYCLOSPORINE OPHTHALMIC EMULSION 0.05% safely and effectively. See full prescribing information for CYCLOSPORINE OPHTHALMIC EMULSION . CYCLOSPORINE ophthalmic emulsion 0.05% For topical ophthalmic use Initial U.S. Approval: 1983 | Mylan Pharmaceuticals Inc. |
| 0378-8760-91 | These highlights do not include all the information needed to use CYCLOSPORINE OPHTHALMIC EMULSION 0.05% safely and effectively. See full prescribing information for CYCLOSPORINE OPHTHALMIC EMULSION . CYCLOSPORINE ophthalmic emulsion 0.05% For topical ophthalmic use Initial U.S. Approval: 1983 | Mylan Pharmaceuticals Inc. |
| 0378-8760-98 | These highlights do not include all the information needed to use CYCLOSPORINE OPHTHALMIC EMULSION 0.05% safely and effectively. See full prescribing information for CYCLOSPORINE OPHTHALMIC EMULSION . CYCLOSPORINE ophthalmic emulsion 0.05% For topical ophthalmic use Initial U.S. Approval: 1983 | Mylan Pharmaceuticals Inc. |
| 0480-4076 | These highlights do not include all the information needed to use CYCLOSPORINE OPHTHALMIC EMULSION 0.05% safely and effectively. See full prescribing information for CYCLOSPORINE OPHTHALMIC EMULSION. CYCLOSPORINE ophthalmic emulsion, 0.05% For topical ophthalmic use Initial U.S. Approval: 1983 | Teva Pharmaceuticals, Inc. |
| 0480-4076-30 | These highlights do not include all the information needed to use CYCLOSPORINE OPHTHALMIC EMULSION 0.05% safely and effectively. See full prescribing information for CYCLOSPORINE OPHTHALMIC EMULSION. CYCLOSPORINE ophthalmic emulsion, 0.05% For topical ophthalmic use Initial U.S. Approval: 1983 | Teva Pharmaceuticals, Inc. |
| 0480-4076-60 | These highlights do not include all the information needed to use CYCLOSPORINE OPHTHALMIC EMULSION 0.05% safely and effectively. See full prescribing information for CYCLOSPORINE OPHTHALMIC EMULSION. CYCLOSPORINE ophthalmic emulsion, 0.05% For topical ophthalmic use Initial U.S. Approval: 1983 | Teva Pharmaceuticals, Inc. |
| 10702-808 | These highlights do not include all the information needed to use CYCLOSPORINE OP H THALMIC EMULSION, 0.05% safely and effectively. See full prescribing information for cyclosporine ophthalmic emulsion, 0.05% . CYCLOSPORINE OP H THALMIC EMULSION, 0.05% For topical ophthalmic use Initial U.S. Approval: 1983 | KVK-TECH, INC. |
| 10702-808-03 | These highlights do not include all the information needed to use CYCLOSPORINE OP H THALMIC EMULSION, 0.05% safely and effectively. See full prescribing information for cyclosporine ophthalmic emulsion, 0.05% . CYCLOSPORINE OP H THALMIC EMULSION, 0.05% For topical ophthalmic use Initial U.S. Approval: 1983 | KVK-TECH, INC. |
| 10702-808-06 | These highlights do not include all the information needed to use CYCLOSPORINE OP H THALMIC EMULSION, 0.05% safely and effectively. See full prescribing information for cyclosporine ophthalmic emulsion, 0.05% . CYCLOSPORINE OP H THALMIC EMULSION, 0.05% For topical ophthalmic use Initial U.S. Approval: 1983 | KVK-TECH, INC. |
| 13744-535 | Modulis ® for Dogs (cyclosporine oral solution) USP MODIFIED 100 mg/mL | Ceva Sante Animale |
| 13744-535-01 | Modulis ® for Dogs (cyclosporine oral solution) USP MODIFIED 100 mg/mL | Ceva Sante Animale |
| 13744-535-02 | Modulis ® for Dogs (cyclosporine oral solution) USP MODIFIED 100 mg/mL | Ceva Sante Animale |
| 13744-535-03 | Modulis ® for Dogs (cyclosporine oral solution) USP MODIFIED 100 mg/mL | Ceva Sante Animale |
| 13744-536 | Modulis ® for Cats (cydosporine oral solution) USP Modified | Ceva Sante Animale |
| 13744-536-01 | Modulis ® for Cats (cydosporine oral solution) USP Modified | Ceva Sante Animale |
| 13744-536-02 | Modulis ® for Cats (cydosporine oral solution) USP Modified | Ceva Sante Animale |
| 17033-261 | Sporimune™ (cyclosporine capsules) USP MODIFIED | Dechra Veterinary Products LLC |
| 17033-261-15 | Sporimune™ (cyclosporine capsules) USP MODIFIED | Dechra Veterinary Products LLC |
| 17033-262 | Sporimune™ (cyclosporine capsules) USP MODIFIED | Dechra Veterinary Products LLC |
| 17033-262-15 | Sporimune™ (cyclosporine capsules) USP MODIFIED | Dechra Veterinary Products LLC |
| 17033-263 | Sporimune™ (cyclosporine capsules) USP MODIFIED | Dechra Veterinary Products LLC |
| 17033-263-15 | Sporimune™ (cyclosporine capsules) USP MODIFIED | Dechra Veterinary Products LLC |
| 23155-837 | CYCLOSPORINE, MODIFIED - cyclosporine capsule, liquid filled Cyclosporine Capsules, USP (MODIFIED) (Soft Gelatin Capsules) Rx only Prescribing Information | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| 23155-837-11 | CYCLOSPORINE, MODIFIED - cyclosporine capsule, liquid filled Cyclosporine Capsules, USP (MODIFIED) (Soft Gelatin Capsules) Rx only Prescribing Information | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| 23155-837-30 | CYCLOSPORINE, MODIFIED - cyclosporine capsule, liquid filled Cyclosporine Capsules, USP (MODIFIED) (Soft Gelatin Capsules) Rx only Prescribing Information | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| 23155-838 | CYCLOSPORINE, MODIFIED - cyclosporine capsule, liquid filled Cyclosporine Capsules, USP (MODIFIED) (Soft Gelatin Capsules) Rx only Prescribing Information | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| 23155-838-11 | CYCLOSPORINE, MODIFIED - cyclosporine capsule, liquid filled Cyclosporine Capsules, USP (MODIFIED) (Soft Gelatin Capsules) Rx only Prescribing Information | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| 23155-838-30 | CYCLOSPORINE, MODIFIED - cyclosporine capsule, liquid filled Cyclosporine Capsules, USP (MODIFIED) (Soft Gelatin Capsules) Rx only Prescribing Information | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| 23155-839 | CYCLOSPORINE, MODIFIED - cyclosporine capsule, liquid filled Cyclosporine Capsules, USP (MODIFIED) (Soft Gelatin Capsules) Rx only Prescribing Information | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| 23155-839-11 | CYCLOSPORINE, MODIFIED - cyclosporine capsule, liquid filled Cyclosporine Capsules, USP (MODIFIED) (Soft Gelatin Capsules) Rx only Prescribing Information | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| 23155-839-30 | CYCLOSPORINE, MODIFIED - cyclosporine capsule, liquid filled Cyclosporine Capsules, USP (MODIFIED) (Soft Gelatin Capsules) Rx only Prescribing Information | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| 24979-126 | These highlights do not include all the information needed to use CYCLOSPORINE OPHTHALMIC EMULSION safely and effectively.see full prescribing information for CYCLOSPORINE OPHTHALMIC EMULSIONCYCLOSPORINE ophthalmic emulsion Initial U.S. Approval: 1983 | Upsher-Smith Laboratories, LLC | TWi Pharmaceuticals, Inc. | Qilu Pharmaceutical Co., Ltd. |
| 24979-126-18 | These highlights do not include all the information needed to use CYCLOSPORINE OPHTHALMIC EMULSION safely and effectively.see full prescribing information for CYCLOSPORINE OPHTHALMIC EMULSIONCYCLOSPORINE ophthalmic emulsion Initial U.S. Approval: 1983 | Upsher-Smith Laboratories, LLC | TWi Pharmaceuticals, Inc. | Qilu Pharmaceutical Co., Ltd. |
| 24979-126-19 | These highlights do not include all the information needed to use CYCLOSPORINE OPHTHALMIC EMULSION safely and effectively.see full prescribing information for CYCLOSPORINE OPHTHALMIC EMULSIONCYCLOSPORINE ophthalmic emulsion Initial U.S. Approval: 1983 | Upsher-Smith Laboratories, LLC | TWi Pharmaceuticals, Inc. | Qilu Pharmaceutical Co., Ltd. |
| 47335-506 | These highlights do not include all the information needed to use CEQUA safely and effectively. See full prescribing information for CEQUA. CEQUA ® (cyclosporine ophthalmic solution) 0.09%, for topical ophthalmic use Initial U.S. Approval: 1983 | Sun Pharmaceutical Industries, Inc. | Laboratoire Unither | TAPI Czech Industries s.r.o. |
| 47335-506 | These highlights do not include all the information needed to use CEQUA safely and effectively. See full prescribing information for CEQUA. CEQUA ® (cyclosporine ophthalmic solution) 0.09%, for topical ophthalmic use Initial U.S. Approval: 1983 | Sun Pharmaceutical Industries, Inc. | Laboratoire Unither | Teva Czech Industries s.r.o |
| 47335-506-96 | These highlights do not include all the information needed to use CEQUA safely and effectively. See full prescribing information for CEQUA. CEQUA ® (cyclosporine ophthalmic solution) 0.09%, for topical ophthalmic use Initial U.S. Approval: 1983 | Sun Pharmaceutical Industries, Inc. | Laboratoire Unither | Teva Czech Industries s.r.o |
| 47335-506-96 | These highlights do not include all the information needed to use CEQUA safely and effectively. See full prescribing information for CEQUA. CEQUA ® (cyclosporine ophthalmic solution) 0.09%, for topical ophthalmic use Initial U.S. Approval: 1983 | Sun Pharmaceutical Industries, Inc. | Laboratoire Unither | TAPI Czech Industries s.r.o. |
| 47335-507 | These highlights do not include all the information needed to use CEQUA safely and effectively. See full prescribing information for CEQUA. CEQUA ® (cyclosporine ophthalmic solution) 0.09%, for topical ophthalmic use Initial U.S. Approval: 1983 | Sun Pharmaceutical Industries, Inc. | Laboratoire Unither | Teva Czech Industries s.r.o |
| 47335-507 | These highlights do not include all the information needed to use CEQUA safely and effectively. See full prescribing information for CEQUA. CEQUA ® (cyclosporine ophthalmic solution) 0.09%, for topical ophthalmic use Initial U.S. Approval: 1983 | Sun Pharmaceutical Industries, Inc. | Laboratoire Unither | TAPI Czech Industries s.r.o. |
| 47335-507-97 | These highlights do not include all the information needed to use CEQUA safely and effectively. See full prescribing information for CEQUA. CEQUA ® (cyclosporine ophthalmic solution) 0.09%, for topical ophthalmic use Initial U.S. Approval: 1983 | Sun Pharmaceutical Industries, Inc. | Laboratoire Unither | Teva Czech Industries s.r.o |
| 47335-507-97 | These highlights do not include all the information needed to use CEQUA safely and effectively. See full prescribing information for CEQUA. CEQUA ® (cyclosporine ophthalmic solution) 0.09%, for topical ophthalmic use Initial U.S. Approval: 1983 | Sun Pharmaceutical Industries, Inc. | Laboratoire Unither | TAPI Czech Industries s.r.o. |
| 50090-1242 | These highlights do not include all the information needed to use RESTASIS ® 0.05% safely and effectively. See full prescribing information for RESTASIS ® . RESTASIS ® ( cyclosporine ophthalmic emulsion ) 0.05% For topical ophthalmic use Initial U.S. Approval: 1983 | A-S Medication Solutions |
| 50090-1242-0 | These highlights do not include all the information needed to use RESTASIS ® 0.05% safely and effectively. See full prescribing information for RESTASIS ® . RESTASIS ® ( cyclosporine ophthalmic emulsion ) 0.05% For topical ophthalmic use Initial U.S. Approval: 1983 | A-S Medication Solutions |
| 50090-4476 | These highlights do not include all the information needed to use RESTASIS ® 0.05% safely and effectively. See full prescribing information for RESTASIS ® . RESTASIS ® ( cyclosporine ophthalmic emulsion ) 0.05% For topical ophthalmic use Initial U.S. Approval: 1983 | A-S Medication Solutions |
| 50090-4476-0 | These highlights do not include all the information needed to use RESTASIS ® 0.05% safely and effectively. See full prescribing information for RESTASIS ® . RESTASIS ® ( cyclosporine ophthalmic emulsion ) 0.05% For topical ophthalmic use Initial U.S. Approval: 1983 | A-S Medication Solutions |
| 51311-994 | CYCLAVANCE® (cyclosporine oral solution) USP MODIFIED | Virbac AH Inc |
| 51311-994-15 | CYCLAVANCE® (cyclosporine oral solution) USP MODIFIED | Virbac AH Inc |
| 51311-994-50 | CYCLAVANCE® (cyclosporine oral solution) USP MODIFIED | Virbac AH Inc |
| 51862-458 | Cyclosporine Capsules, USP [Modified](Soft Gelatin) Cyclosporine ORAL SOLUTION, USP [Modified] | Mayne Pharma Inc. | Patheon Softgels Inc. | Carton Service Incorporated | Sharp Corporation |
| 51862-458-01 | Cyclosporine Capsules, USP [Modified](Soft Gelatin) Cyclosporine ORAL SOLUTION, USP [Modified] | Mayne Pharma Inc. | Patheon Softgels Inc. | Carton Service Incorporated | Sharp Corporation |
| 51862-458-47 | Cyclosporine Capsules, USP [Modified](Soft Gelatin) Cyclosporine ORAL SOLUTION, USP [Modified] | Mayne Pharma Inc. | Patheon Softgels Inc. | Carton Service Incorporated | Sharp Corporation |
| 51862-460 | Cyclosporine Capsules, USP [Modified](Soft Gelatin) Cyclosporine ORAL SOLUTION, USP [Modified] | Mayne Pharma Inc. | Patheon Softgels Inc. | Carton Service Incorporated | Sharp Corporation |
| 51862-460-01 | Cyclosporine Capsules, USP [Modified](Soft Gelatin) Cyclosporine ORAL SOLUTION, USP [Modified] | Mayne Pharma Inc. | Patheon Softgels Inc. | Carton Service Incorporated | Sharp Corporation |
| 51862-460-47 | Cyclosporine Capsules, USP [Modified](Soft Gelatin) Cyclosporine ORAL SOLUTION, USP [Modified] | Mayne Pharma Inc. | Patheon Softgels Inc. | Carton Service Incorporated | Sharp Corporation |